Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIAP.L Regulatory News (IAP)

  • There is currently no data for IAP

ICAP launches ISDX

31 Oct 2012 10:00

RNS Number : 9417P
ICAP PLC
31 October 2012
 



ICAP launches ICAP Securities & Derivatives Exchange (ISDX)

the new small and mid cap equity listings venue for SMEs

 

London, 31 October 2012 - ICAP (IAP.L), the world's leading interdealer broker and provider of post trade risk and information services, today announces the launch of ICAP Securities & Derivatives Exchange (ISDX), the listing venue for small and medium sized enterprises seeking access to equity capital to finance and grow their businesses.

 

This launch and rebranding follows ICAP's purchase of PLUS Stock Exchange plc on 21 June when ICAP committed to supporting and expanding the listings venue. At ICAP's offices in London today a number of ISDX companies will present to an audience of investors, advisors, market makers and other stakeholders. Companies presenting are Bioventix plc, Central Asian Minerals and Resources plc, Chapel Down Group plc, Daniel Thwaites plc, One Media iP Group plc, Quercus Publishing plc, Shepherd Neame Ltd and Sprue Aegis plc.

 

At the presentation ICAP will announce a series of initiatives which have been developed in close consultation with the market and draw on ICAP's extensive experience and expertise as a markets operator. These include:

 

·; the provision of increased liquidity to the market by the addition of two leading market makers, Peel Hunt and Shore Capital, which will make markets in ISDX's largest stocks to ensure the exchange operates as an orderly primary and secondary marketplace;

 

·; a focus on increasing the quality of the companies listed on the exchange, including the introduction of a new admissions framework in 2013, to ensure stricter common standards for companies joining ISDX and strengthen investor confidence; and

 

·; a new exchange website, www.isdx.com. This will provide real-time pricing information, news, account downloads and charting information and so allow companies to communicate more effectively with investors.

 

ISDX will allow companies to raise capital on the primary market and investors to trade shares in these companies on an active secondary market. The exchange will be a viable alternative listings venue to support the growth ambitions of SMEs, providing them with widespread exposure to their current and potential investors.

 

ICAP has established a new management team committed to the development and success of the exchange. This team is led by Seth Johnson CEO of ICAP Securities & Derivatives Exchangeand member of ICAP's Global Executive Management Group.

 

Michael Spencer, Group CEO of ICAP, said:"As someone who has founded and grown a business I know how important it is to be able to access development capital. I'm very pleased that ICAP is providing SMEs with a well-run and well-supported listings venue, with a clear and transparent route to market, to support their long-term growth ambitions. SMEs are vitally important to the UK economy and ICAP is committed to developing ISDX for the benefit of the whole business and financial community."

 

Seth Johnson, CEO of ICAP Securities & Derivatives Exchange, said: "The launch of ICAP Securities & Derivatives Exchange today is great news for smaller companies and their investors. Companies seeking to list will benefit from a clear and straightforward route to market. Investors will gain access to exciting growth opportunities and with market makers committed to providing liquidity, they will be able to trade these shares with confidence.

We are committed to the success of this exchange and as an experienced markets operator, ICAP has the right skills and knowledge to make this the venue of choice for SMEs seeking equity capital."

 

Peter Harrison, CEO of Bioventix said: "ICAP has demonstrated they are committed to the success of this exchange as an SME listing and trading venue, which will give companies like Bioventix widespread exposure and access to capital. Creating a strong primary and liquid secondary market is extremely welcome and we are delighted to be able to benefit from ICAP's vast markets expertise."

 

Paul Stevens, Fund Manager at Octopus Investments said: "This is an important and dynamic part of the equities market that investors want to access. The ability to trade these stocks with low transaction costs and immediacy of trading makes this a very attractive market to invest through. ICAP's commitment to this market and to providing a liquid secondary market will ensure investors can trade these stocks with confidence."

 

Nick Conyerd of Market Maker Shore Capital said: "We recognise there is investor demand to trade stocks on this exchange and are committed to providing liquidity. In creating ICAP Securities & Derivatives Exchange, ICAP has responded to the need for an SME equity market that can function effectively alongside new European Union regulations and we are looking forward to working with them to make this exchange a success."

 

Tim Ward, CEO of the Quoted Companies Alliance said:"There are nearly 2,000 small and mid-size quoted companies in the UK, representing 85% of all quoted companies. Access to capital is one of the most important issues for our members. The launch of ICAP Securities & Derivatives Exchange is great news for all such companies. They are the UK's engines of growth and their performance will drive our future economic success."

 

Contacts:

 

Serra Balls

Head of Public Relations

+44 (0) 20 7050 7124

Alex Dee

Head of Investor Relations

+44 (0) 20 7050 7123

Andy Donald

Maitland

+44 (0) 20 7379 5151

 

Notes to Editors:

 

About ICAPICAP is the world's leading interdealer broker and provider of post trade risk and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information go to www.icap.com.

 

About ICAP Securities & Derivatives Exchange

ICAP Securities & Derivatives Exchange is a Recognised Investment Exchange (RIE) under the Financial Services & Markets Act 2000. It is an equity market for small and medium sized companies, who want to raise money from investors to finance and grow their businesses. ICAP acquired the RIE license through its purchase of PLUS Stock Exchange plc on 21 June 2012. For more information go to www.isdx.com.

 

About Seth Johnson

Seth Johnson joined ICAP's electronic markets in November 2011 to lead the expansion of its product portfolio. In this role he is the co-head of BrokerTec, ICAP's fixed income electronic trading platform, and the CEO of ICAP Securities & Derivatives Exchange.

 

Seth joined ICAP as a graduate trainee and has worked at the company for more than 20 years. For ten years, he was the Managing Director of the Interest Rates, Options and Inflation Swaps desks. He oversaw the introduction of new and innovative trading solutions, including the volume match system currently used by the ICAP Inflation and Options desks in London.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGCBDGSDXBGDB
Date   Source Headline
20th Aug 20142:16 pmRNSHolding(s) in Company
15th Aug 201410:00 amRNSBlocklisting Interim Review
15th Aug 201410:00 amRNSBlocklisting Interim Review
15th Aug 201410:00 amRNSBlocklisting Interim Review
8th Aug 20142:39 pmRNSTreasury Stock
5th Aug 20141:35 pmRNSICAP Electronic Broking - July 2014 Volumes
1st Aug 20144:51 pmRNSHolding(s) in Company
1st Aug 201411:11 amRNSTotal Voting Rights
1st Aug 201411:02 amRNSTreasury Stock
28th Jul 20142:20 pmRNSDirector/PDMR Shareholding
18th Jul 201411:11 amRNSTreasury Stock
16th Jul 201412:18 pmRNSResult of AGM
16th Jul 20147:30 amRNSHolding(s) in Company
16th Jul 20147:00 amRNSInterim Management Statement
3rd Jul 201410:30 amRNSICAP Electronic Broking - June 2014 Volumes
2nd Jul 20141:44 pmRNSDirector/PDMR Shareholding
1st Jul 201411:08 amRNSTotal Voting Rights
23rd Jun 20145:27 pmRNSHolding(s) in Company
13th Jun 20141:33 pmRNSDirector/PDMR Shareholding
12th Jun 20145:44 pmRNSHolding(s) in Company
10th Jun 20145:20 pmRNSAnnual Financial Report
10th Jun 201411:12 amRNSResponse to Statement of Objections from the EC
9th Jun 20146:20 pmRNSDirector/PDMR Shareholding
5th Jun 20149:00 amRNSICAP Electronic Broking - May 2014 Volumes
4th Jun 201411:30 amRNSICAP's i-Swap USD interest rate swap volume record
2nd Jun 201410:14 amRNSTotal Voting Rights
28th May 201411:19 amRNSDirector/PDMR Shareholding
23rd May 201410:30 amRNSHolding(s) in Company
22nd May 20145:31 pmRNSDirector/PDMR Shareholding
16th May 20143:30 pmRNSTreasury Stock
15th May 20145:30 pmRNSTreasury Stock
14th May 20145:26 pmRNSDirector/PDMR Shareholding
14th May 20147:00 amRNSFull Year Results for Year Ended 31 March 2014
7th May 201411:11 amRNSICAP Electronic Broking - April 2014 Volumes
1st May 201411:26 amRNSTotal Voting Rights
23rd Apr 20145:06 pmRNSTransaction in Own Shares
16th Apr 20142:55 pmRNSPublication of Final Terms
4th Apr 20149:30 amRNSICAP Electronic Broking - March 2014 Volumes
1st Apr 201410:14 amRNSTotal Voting Rights
1st Apr 20147:00 amRNSTrading Statement
31st Mar 201412:03 pmRNSICAP plc board change
5th Mar 20149:10 amRNSICAP Electronic Broking - February 2014 Volumes
4th Mar 20145:00 pmRNSPublication of Final Terms
3rd Mar 201410:23 amRNSTotal Voting Rights
27th Feb 20144:54 pmRNSICAP Group Holdings plc: Successful Bond Offering
19th Feb 20144:24 pmRNSTreasury Stock
17th Feb 20145:00 pmRNSPublication of Base Prospectus Supplement
14th Feb 20141:30 pmRNSBlocklisting Interim Review
14th Feb 20141:30 pmRNSBlocklisting Interim Review
14th Feb 20141:30 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.